HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 1,201-1,212 of 4,505
Drug study icon
CompletedNCT01354132

N-Acetyl-Cysteine (NAC) in Early Phase Schizophrenia Spectrum Psychosis

Official study title

Effects of Oral N-Acetyl-Cysteine (NAC) in the Early Phase of Schizophrenia Spectrum Psychosis: Randomized, Parallel, Double- Blind, Placebo Controlled Trial

This study has finished and is no longer accepting participants.

In Boston
SchizophreniaMedication studyAges 18–35
Countries
United States
Sponsor
Beth Israel Deaconess Medical Center
Other study type icon
CompletedNCT03995368

Neuroplasticity in TBI and Schizophrenia

Official study title

New Applications of Neuroplasticity Biomarkers in Veterans With Traumatic Brain Injury or Schizophrenia

This study has finished and is no longer accepting participants.

In West Los Angeles
SchizophreniaInterventional studyAges 25–55
Countries
United States
Sponsor
VA Office of Research and Development (Government agency)
Biological study icon
CompletedNCT02458924

Niacin Skin Flush Response in people with Schizophrenia

Official study title

Niacin Skin Flush Response in Patients With Schizophrenia, Their First Degree Relatives, Bipolar Disorder Patients, and Healthy Controls

This study has finished and is no longer accepting participants.

Location not clearly listed
SchizophreniaInterventional studyAges 18–65
Countries
Sponsor
Isfahan University of Medical Sciences
Other study type icon
Active Not RecruitingNCT06370793

Ningbo Schizophrenia Cohort

Official study title

Ningbo Schizophrenia Cohort, a Longitudinal Population-based Ambispective Cohort Study

This study is no longer accepting new participants.

In Ningbo
SchizophreniaObservational studyAges 18–65
Countries
China
Sponsor
Ningbo University
Other study type icon
CompletedNCT05480046

Non-interventional Study of Risperidone ISM® in Schizophrenia Patients Hospitalised Due to a Relapse

Official study title

Risperidone ISM® Effectiveness in Schizophrenia Patients Hospitalised Due to A Relapse: a Prospective Non-interventional Evaluation (RESHAPE Study)

This study has finished and is no longer accepting participants.

Multiple locations, including Aachen
SchizophreniaObservational studyAges 18+
Countries
United Kingdom, Germany, Italy, + 2 others
Sponsor
Rovi Pharmaceuticals Laboratories
Drug study icon
CompletedNCT02230384

Novel Smoking Cessation Drug for Schizophrenia

Official study title

The Development of of A Novel Therapeutic to Aid Tobacco Smoking Cessation in Persons With Schizophrenia or Schizoaffective Disorder

This study has finished and is no longer accepting participants.

In Pittsburgh
SchizophreniaMedication studyAges 18–66
Countries
United States
Sponsor
K.N. Roy Chengappa
Other study type icon
CompletedNCT04312503

Observational Study on the Effect of Switch to Lurasidone in Subjects With Schizophrenia"

Official study title

Observational Study on the Effect of Switch to Lurasidone or Other Antipsychothics on Metabolic and Weight Changes in Subjects With Schizophrenia"

This study has finished and is no longer accepting participants.

Multiple locations, including Ancona
SchizophreniaObservational studyAges 18+
Countries
Italy
Sponsor
Aziende Chimiche Riunite Angelini Francesco S.p.A

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.